Atlas Trials

Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis

Clinical trial NCT00622895 · COMPLETED

Trial details

NCT number
NCT00622895
Sponsor
Fred Hutchinson Cancer Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Systemic SclerodermaSevere Systemic Sclerosis
Start date
2006-09-01
Primary completion
2011-11-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.